Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Smoking Cessation Patch, Gum Prop 65 Warning Federally Preempted - Court

This article was originally published in The Tan Sheet

Executive Summary

Requiring a special California Proposition 65 pregnancy warning on OTC nicotine-containing smoking cessation patches and gums would conflict with FDA requirements, a San Francisco state court judge has ruled.
Advertisement

Related Content

Kaopectate Prop 65
FDA Prop 65 NRT Warning Rejection Should Be Given Deference, Firms Say
Prop 65 Smoking Cessation Warnings Not In Conflict With FDA Rules – Court
Prop 65 Andro Litigation Could Include Mini-Trial On Anabolic Steroid Status
Nicotine patch safe during pregnancy
Prop 65
OTC Coal Tar Skin Cancer Causation Data Lacking - FDA
Smoking Rate 25% Annual Reduction Attainable - Surgeon General
Novartis OTC Habitrol Taking Private Label Tack
Novartis OTC Habitrol Taking Private Label Tack

Topics

Advertisement
UsernamePublicRestriction

Register

PS092353

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel